Rockwell Medical, Inc.
- RMTI
- NASDAQ
- Drug Manufacturers - Specialty & Generic
- Kidney Disease Therapies
- Hemodialysis Products
$7.49
Today +0.81%Quote Oct 19, 2026, 08:00 PM UTC
−6.07%over the last month
Max drawdown −16.5%From 1-month high −16.5%3 months +17.9%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Rockwell Medical
Rockwell Medical, Inc., together with its associated companies, operates as a biopharmaceutical firm specializing in treatments for chronic and end-stage kidney disease. The company provides a range of therapies and products aimed at addressing iron deficiency and supporting hemodialysis procedures, serving markets both within the United States and internationally.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Employees
157
Market value
$30.2M
Quote Oct 19
Analyst target
$20.00
+167.0% from here
Floor
$7.48
0.2% below price
Resistance
$7.70
2.8% above price
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about RMTIPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free